Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AZN

AstraZeneca

$37.03

0.15 (0.41%)

15:40
05/25/18
05/25
15:40
05/25/18
15:40
Options
AstraZeneca call buyer opens position 4% above spot »

AstraZeneca call buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

PYPL

PayPal

$81.04

-0.51 (-0.63%)

, NVS

Novartis

$76.76

0.58 (0.76%)

10:28
05/25/18
05/25
10:28
05/25/18
10:28
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

PYPL

PayPal

$81.04

-0.51 (-0.63%)

NVS

Novartis

$76.76

0.58 (0.76%)

CL

Colgate-Palmolive

$63.63

1.14 (1.82%)

BSTI

Best Inc.

$11.46

0.25 (2.23%)

LOMA

Loma Negra

$12.53

1.01 (8.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

AMGN

Amgen

$178.42

0.47 (0.26%)

10:03
05/25/18
05/25
10:03
05/25/18
10:03
Hot Stocks
Amgen's Nplate granted FDA orphan designation »

Amgen's Nplate,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 02

    Jun

AZN

AstraZeneca

$36.88

0.035 (0.09%)

06:57
05/25/18
05/25
06:57
05/25/18
06:57
Hot Stocks
AstraZeneca says Imfinzi met second primary endpoint in PACIFIC trial »

AstraZeneca and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

NVS

Novartis

$76.18

-0.2 (-0.26%)

06:05
05/25/18
05/25
06:05
05/25/18
06:05
Upgrade
Novartis rating change at Credit Suisse »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 05

    Jun

Thursday
MRK

Merck

$59.11

-0.05 (-0.08%)

, ESALY

Eisai

$0.00

(0.00%)

19:43
05/24/18
05/24
19:43
05/24/18
19:43
Hot Stocks
Eisai, Merck provide update on sNDA for Lenvatinib in HCC »

Eisai (ESALY). and Merck…

MRK

Merck

$59.11

-0.05 (-0.08%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

AZN

AstraZeneca

$36.85

-0.205 (-0.55%)

08:18
05/24/18
05/24
08:18
05/24/18
08:18
Hot Stocks
AstraZeneca to present diversified oncology portfolio at ASCO »

AstraZeneca and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

BAC

Bank of America

$30.45

-0.44 (-1.42%)

, JD

JD.com

$36.72

0.35 (0.96%)

07:35
05/24/18
05/24
07:35
05/24/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$30.45

-0.44 (-1.42%)

JD

JD.com

$36.72

0.35 (0.96%)

TWX

Time Warner

$93.99

-0.43 (-0.46%)

MRK

Merck

$59.16

0.7 (1.20%)

EBAY

eBay

$38.04

0.27 (0.71%)

KMI

Kinder Morgan

$16.19

0.245 (1.54%)

GLW

Corning

$27.76

0.115 (0.42%)

SU

Suncor

$40.68

-0.36 (-0.88%)

GERN

Geron

$4.67

0.6 (14.74%)

CWH

Camping World

$19.28

-2.12 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 10

    Sep

  • 23

    Oct

FMI

Foundation Medicine

$85.80

0.95 (1.12%)

, MRK

Merck

$59.16

0.7 (1.20%)

07:07
05/24/18
05/24
07:07
05/24/18
07:07
Hot Stocks
Foundation Medicine, Merck to collaborate on diagnostic tests with Keytruda »

Foundation Medicine (FMI)…

FMI

Foundation Medicine

$85.80

0.95 (1.12%)

MRK

Merck

$59.16

0.7 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 10

    Sep

  • 23

    Oct

NKTR

Nektar

$82.81

0.87 (1.06%)

, BMY

Bristol-Myers

$52.49

0.14 (0.27%)

05:36
05/24/18
05/24
05:36
05/24/18
05:36
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary at Mizuho »

Nektar is…

NKTR

Nektar

$82.81

0.87 (1.06%)

BMY

Bristol-Myers

$52.49

0.14 (0.27%)

MRK

Merck

$59.16

0.7 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.